ADAR1 Capital Management reports $56,041 InMed Pharmaceuticals common share purchase

PUBT · 1d ago
ADAR1 Capital Management reports $56,041 InMed Pharmaceuticals common share purchase
  • ADAR1 Capital Management, a 10% owner of InMed Pharmaceuticals, reported additional purchases of common shares.
  • Holdings rose to 935,021 common shares, held indirectly through private investment funds it manages.
  • Daniel Schneeberger, manager of ADAR1 Capital Management, was listed as an indirect beneficial owner.
  • Purchases were reported at prices of USD 1.3298 and USD 1.33 per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InMed Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001940272-26-000022), on October 05, 2026, and is solely responsible for the information contained therein.